Actively Recruiting
Dynamics of Markers of Infection and Inflammation in Hospitalized Coronavirus Disease 2019 (COVID-19) Patients
Led by University Hospital Hradec Kralove · Updated on 2024-05-10
30
Participants Needed
1
Research Sites
278 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Patients requiring admission to the hospital due to a moderate and severe COVID-19 infection may differ in their ability to respond to viral infection and to eliminate viral load. Several comorbidities and interventions like antivirotic or antiinflammatory treatment may also modify expected patients response and decrease of viral load. In this observational study, evolution of selected inflammatory markers, indicators of severity of infection and patient characteristics will be followed and recorded in hospitalized patients with COVID-19.
CONDITIONS
Official Title
Dynamics of Markers of Infection and Inflammation in Hospitalized Coronavirus Disease 2019 (COVID-19) Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Positive SARS CoV2 test within the last 14 days
- Bilateral infiltrates on chest X-ray or CT scan
- Need for oxygen to keep pulse oximetry saturation above 92% or require respiratory support such as HFNO, non-invasive or invasive ventilation
- Age between 18 and 90 years
You will not qualify if you...
- Known history of interstitial lung disease
- Known history of congestive heart failure
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospital Hradec Kralove
Hradec Králové, Czechia, 50005
Actively Recruiting
Research Team
P
Pavel Dostál, MD, PhD
CONTACT
V
Vladimir Koblizek, MD, Ph.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here